ArticleDiabetes care2026

Generalizability of Progression Risk in the TN-10 Trial to a European Population With or Without a First-Degree Relative With Type 1 Diabetes.

Melanie Koeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.